Invention Grant
- Patent Title: Oligonucleotide sequence for use in pathway engineering
-
Application No.: US15529577Application Date: 2015-11-16
-
Publication No.: US10400244B2Publication Date: 2019-09-03
- Inventor: Zdravko Dragovic , Christoph Reisinger , Heiko Dietz
- Applicant: CLARIANT INTERNATIONAL LTD.
- Applicant Address: CH Muttenz
- Assignee: Clariant International Ltd.
- Current Assignee: Clariant International Ltd.
- Current Assignee Address: CH Muttenz
- Agency: Verrill Dana, LLP
- Priority: EP14195026 20141126
- International Application: PCT/EP2015/076715 WO 20151116
- International Announcement: WO2016/083180 WO 20160602
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C12N15/79 ; C12N15/67

Abstract:
The present invention comprises a novel artificial oligonucleotide sequence which can initiate the transcription of a gene under various conditions at a high level. Further the invention relates to a recombinant DNA fragment comprising the artificial oligonucleotide sequence, an expression plasmid comprising the recombinant DNA fragment and a host cell transformed with the recombinant DNA fragment.
Public/Granted literature
- US20170314029A1 OLIGONUCLEOTIDE SEQUENCE FOR USE IN PATHWAY ENGINEERING Public/Granted day:2017-11-02
Information query
IPC分类: